The pathophysiological changes of experimental fat embolism: early pre-hypoxaemic changes

Area of Science:

• Physiology
• Pathophysiology

Background:

• Fat embolism syndrome (FES) is a serious complication following trauma, particularly fractures.
• The precise mechanisms underlying FES pathogenesis remain incompletely understood.
• Glyceryl trioleate serves as a validated lipid emulsion for modeling FES in vivo.

Purpose of the Study:

• To investigate the hemodynamic effects of glyceryl trioleate-induced fat embolism syndrome in a canine model.
• To elucidate the mechanisms contributing to the pathophysiology of FES.

Main Methods:

• Greyhounds were intravenously administered glyceryl trioleate.
• Hemodynamic parameters including pulmonary vascular pressures, systemic arterial pressure, and cardiac output were monitored over an 8-hour period.

Main Results:

• Intravenous infusion of glyceryl trioleate led to a significant increase in pulmonary vascular resistance.
• A notable decrease in cardiac output was observed following glyceryl trioleate administration.
• Evidence suggests both mechanical obstruction and thrombogenic properties of the fat contribute to these effects.

Conclusions:

• Glyceryl trioleate administration in greyhounds accurately replicates key hemodynamic changes observed in clinical fat embolism syndrome.
• The findings support a dual mechanism involving mechanical blockage and fat-induced thrombogenesis in FES.
• A proposed sequence of events for FES pathophysiology is discussed in relation to the clinical context.